Arne T Lundin

Title: Arne T Lundin: Innovator in Bioluminescence and Photometric Determination

Introduction

Arne T Lundin is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the fields of bioluminescence and photometric determination through his innovative patents. With a total of 2 patents, Lundin's work has advanced the understanding and application of biochemical processes.

Latest Patents

Lundin's latest patents include a "Method and reagent for bioluminescence," which improves the process for determining the concentration of adenosinetriphosphate (ATP) in ATP-converting reactions. This method utilizes a bioluminescent reagent based on D-luciferin, luciferase, and magnesium ions, where the emitted light is a function of the ATP concentration. The invention incorporates competitive inhibitors, such as D-luciferin analogues, to enhance the accuracy of the assay.

Another significant patent is the "Method for photometric determination of the subunit B of creatine kinase." This method allows for the photometric determination of CK-B in buffered water solutions through a reaction involving creatine phosphate, ADP, and luciferase/D-luciferin systems. The method employs specific antibodies to inhibit the subunit M of creatine kinase, utilizing D-luciferin analogs as competitive inhibitors to improve the determination process.

Career Highlights

Throughout his career, Arne T Lundin has worked with various companies, including LKB-Produkter AB. His expertise in biochemistry and innovative approaches have positioned him as a key figure in his field. Lundin's contributions have not only advanced scientific understanding but have also paved the way for practical applications in medical and biochemical research.

Collaborations

Lundin has collaborated with notable professionals in his field, including Arne Myhrman. These collaborations have further enriched his work and contributed to the development of his innovative patents.

Conclusion

Arne T Lundin's contributions to bioluminescence and photometric determination exemplify the impact of innovation in scientific research. His patents reflect a commitment to advancing biochemical methodologies, making significant strides in the understanding of ATP and creatine kinase. Lundin's work continues to influence the field and inspire future innovations.